Robert I Tepper's Net Worth

$1.5 Billion

Who is Robert I Tepper?

Robert I Tepper has an estimated net worth of $1.5 Billion. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., Revolution Medicines, Inc., PLIANT THERAPEUTICS, INC., Editas Medicine, Inc., Jounce Therapeutics, Inc., Voyager Therapeutics, Inc., Blueprint Medicines Corp, Nurix Therapeutics, Inc., bluebird bio, Inc., Global Blood Therapeutics, Inc., Sage Therapeutics, Inc., Relay Therapeutics, Inc., MyoKardia Inc, Neon Therapeutics, Inc., Foundation Medicine, Inc., ZAFGEN, INC., Cerulean Pharma Inc., Allena Pharmaceuticals, Inc., Decibel Therapeutics, Inc., Eleven Biotherapeutics, Inc., CytomX Therapeutics, Inc., Kala Pharmaceuticals, Inc., and MILLENNIUM PHARMACEUTICALS INC.

SEC CIK

Robert I Tepper's CIK is 0001192595

Past Insider Trading and Trends

2015 was Robert I Tepper's most active year for acquiring shares with 30 total transactions. Robert I Tepper's most active month to acquire stocks was the month of May. 2017 was Robert I Tepper's most active year for disposing of shares, totalling 41 transactions. Robert I Tepper's most active month to dispose stocks was the month of December. 2018 saw Robert I Tepper paying a total of $4,079,104.60 for 3,046,765 shares, this is the most they've acquired in one year. In 2021 Robert I Tepper cashed out on 21,434,231 shares for a total of $322,683,542.21, their largest year based on trade value.